Biocon Biologics’ sponsored report suggests ways to increase adoption of Biosimilars in poor countries
Clarity in regulatory frameworks and pathways help in preventing delays in accessing quality-assured, affordable medicines
Clarity in regulatory frameworks and pathways help in preventing delays in accessing quality-assured, affordable medicines
Strategic focus on COCO-model with a nationwide reach of 501 stores
Poor oral health (periodontal disease) impacts nearly 51% of Indians
Clariant is launching high-performing pharmaceutical ingredients to support the evolution of safe and effective medicines
Quinidine Sulphate helps manage rare irregular heartbeat conditions
Investment in new plant meets increasing demand for functional excipients for oral drug delivery
Lilly will license certain baricitinib manufacturing know-how to enable EVA Pharma to manufacture and supply treatment for various immunological diseases
The Academy, led by Professor Ravi P Mahajan CBE, is set to harmonize the efforts of various Apollo entities
Bortezomib Injection is approved for subcutaneous or intravenous use. It is available as a single dose vial of 3.5 mg/1.4 mL (2.5 mg/mL)
Subscribe To Our Newsletter & Stay Updated